Invent Bio-Med Profile
Key Indicators
- Authorised Capital ₹ 30.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 24.70 Cr
as on 24-10-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 25.08 Cr
as on 24-10-2024
- Revenue 202.16%
(FY 2023)
- Profit 133.60%
(FY 2023)
- Ebitda 107.29%
(FY 2023)
- Net Worth 29.06%
(FY 2023)
- Total Assets 35.99%
(FY 2023)
About Invent Bio-Med
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 30.00 Cr and a paid-up capital of Rs 24.70 Cr.
The company has closed loans amounting to ₹25.08 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Invent Bio-Med Private Limited India is Sagar Rajvanshi as COMPANY SECRETARY. Rajkumar Manglunia, Shyam Manglunia, Amit Agrawal, and One other member serve as directors at the Company.
- CIN/LLPIN
U33110MH2005PTC152988
- Company No.
152988
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 May 2005
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- LocationMumbai, Maharashtra
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Invent Bio-Med Private Limited offer?
Invent Bio-Med Private Limited offers a wide range of products and services, including Forceps & Graspers, Surgical Equipments, Industrial Pipe & Tube Fittings, Pipe Connectors, Infusion Syringes & Supplies, Catheter, Guide Wire, Physiotherapy Equipment, Sequential Compression Device, Surgical Accessories.
Who are the key members and board of directors at Invent Bio-Med?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sagar Rajvanshi | Company Secretary | 24-Sep-2024 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Rajkumar Manglunia  | Director | 08-Aug-2017 | Current |
| Shyam Manglunia | Director | 08-Aug-2017 | Current |
| Amit Agrawal | Director | 16-May-2022 | Current |
| Ronak Manglunia | Director | 08-Aug-2017 | Current |
Financial Performance and Corporate Structure Insights of Invent Bio-Med.
Invent Bio-Med Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 202.16% increase. The company also saw a substantial improvement in profitability, with a 133.6% increase in profit. The company's net worth Soared by an impressive increase of 29.06%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Invent Bio-Med?
In 2023, Invent Bio-Med had a promoter holding of 43.10% and a public holding of 56.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Mohini Organics Private LimitedActive 34 years 1 monthRajkumar Manglunia and Shyam Manglunia are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Punjab National Bank Creation Date: 12 Jun 2012 | ₹9.10 Cr | Satisfied |
Small Industries Development Bank Of India Creation Date: 27 Jan 2012 | ₹3.50 M | Satisfied |
Punjab National Bank Creation Date: 07 Jul 2011 | ₹7.23 Cr | Satisfied |
How Many Employees Work at Invent Bio-Med?
Invent Bio-Med has a workforce of 15 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Invent Bio-Med, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Invent Bio-Med's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
